192 related articles for article (PubMed ID: 32634134)
1. Chlamydial-Secreted Protease Chlamydia High Temperature Requirement Protein A (cHtrA) Degrades Human Cathelicidin LL-37 and Suppresses Its Anti-Chlamydial Activity.
Dong X; Zhang W; Hou J; Ma M; Zhu C; Wang H; Hou S
Med Sci Monit; 2020 Jul; 26():e923909. PubMed ID: 32634134
[TBL] [Abstract][Full Text] [Related]
2. Chlamydia-secreted protease CPAF degrades host antimicrobial peptides.
Tang L; Chen J; Zhou Z; Yu P; Yang Z; Zhong G
Microbes Infect; 2015 Jun; 17(6):402-8. PubMed ID: 25752416
[TBL] [Abstract][Full Text] [Related]
3. The chlamydial periplasmic stress response serine protease cHtrA is secreted into host cell cytosol.
Wu X; Lei L; Gong S; Chen D; Flores R; Zhong G
BMC Microbiol; 2011 Apr; 11():87. PubMed ID: 21527029
[TBL] [Abstract][Full Text] [Related]
4. Chlamydial plasmid-encoded virulence factor Pgp3 neutralizes the antichlamydial activity of human cathelicidin LL-37.
Hou S; Dong X; Yang Z; Li Z; Liu Q; Zhong G
Infect Immun; 2015 Dec; 83(12):4701-9. PubMed ID: 26416907
[TBL] [Abstract][Full Text] [Related]
5. Chlamydial plasmid-encoded virulence factor Pgp3 interacts with human cathelicidin peptide LL-37 to modulate immune response.
Hou S; Sun X; Dong X; Lin H; Tang L; Xue M; Zhong G
Microbes Infect; 2019; 21(1):50-55. PubMed ID: 29959096
[TBL] [Abstract][Full Text] [Related]
6. Peptidase Inhibitor 15 (PI15) Regulates Chlamydial CPAF Activity.
Prusty BK; Chowdhury SR; Gulve N; Rudel T
Front Cell Infect Microbiol; 2018; 8():183. PubMed ID: 29900129
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.
Zaiou M; Nizet V; Gallo RL
J Invest Dermatol; 2003 May; 120(5):810-6. PubMed ID: 12713586
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia trachomatis secretion of proteases for manipulating host signaling pathways.
Zhong G
Front Microbiol; 2011; 2():14. PubMed ID: 21687409
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of human cathelicidin LL-37 by free fatty acids and their analogs.
Jiang W; Sunkara LT; Zeng X; Deng Z; Myers SM; Zhang G
Peptides; 2013 Dec; 50():129-38. PubMed ID: 24140860
[TBL] [Abstract][Full Text] [Related]
10. The temperature activated HtrA protease from pathogen Chlamydia trachomatis acts as both a chaperone and protease at 37 degrees C.
Huston WM; Swedberg JE; Harris JM; Walsh TP; Mathews SA; Timms P
FEBS Lett; 2007 Jul; 581(18):3382-6. PubMed ID: 17604025
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of human and murine Chlamydia trachomatis serovars to granulocyte- and epithelium-derived antimicrobial peptides.
Chong-Cerrillo C; Selsted ME; Peterson EM; de la Maza LM
J Pept Res; 2003 May; 61(5):237-42. PubMed ID: 12662357
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial Peptide Conformation as a Structural Determinant of Omptin Protease Specificity.
Brannon JR; Thomassin JL; Gruenheid S; Le Moual H
J Bacteriol; 2015 Nov; 197(22):3583-91. PubMed ID: 26350132
[TBL] [Abstract][Full Text] [Related]
13. Role of uropathogenic Escherichia coli OmpT in the resistance against human cathelicidin LL-37.
Brannon JR; Thomassin JL; Desloges I; Gruenheid S; Le Moual H
FEMS Microbiol Lett; 2013 Aug; 345(1):64-71. PubMed ID: 23710656
[TBL] [Abstract][Full Text] [Related]
14. Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.
Wang G; Narayana JL; Mishra B; Zhang Y; Wang F; Wang C; Zarena D; Lushnikova T; Wang X
Adv Exp Med Biol; 2019; 1117():215-240. PubMed ID: 30980360
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.
Rapala-Kozik M; Bochenska O; Zawrotniak M; Wolak N; Trebacz G; Gogol M; Ostrowska D; Aoki W; Ueda M; Kozik A
Infect Immun; 2015 Jun; 83(6):2518-30. PubMed ID: 25847962
[TBL] [Abstract][Full Text] [Related]
16. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.
Sieprawska-Lupa M; Mydel P; Krawczyk K; Wójcik K; Puklo M; Lupa B; Suder P; Silberring J; Reed M; Pohl J; Shafer W; McAleese F; Foster T; Travis J; Potempa J
Antimicrob Agents Chemother; 2004 Dec; 48(12):4673-9. PubMed ID: 15561843
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of Chlamydia suis to cathelicidin peptides.
Donati M; Di Francesco A; Gennaro R; Benincasa M; Magnino S; Pignanelli S; Shurdhi A; Moroni A; Mazzoni C; Merialdi G; Baldelli R; Cevenini R
Vet Microbiol; 2007 Jul; 123(1-3):269-73. PubMed ID: 17391870
[TBL] [Abstract][Full Text] [Related]
18. Epithelial antimicrobial peptides in host defense against infection.
Bals R
Respir Res; 2000; 1(3):141-50. PubMed ID: 11667978
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin.
Yamasaki K; Schauber J; Coda A; Lin H; Dorschner RA; Schechter NM; Bonnart C; Descargues P; Hovnanian A; Gallo RL
FASEB J; 2006 Oct; 20(12):2068-80. PubMed ID: 17012259
[TBL] [Abstract][Full Text] [Related]
20. A Novel Cleavage Pattern of Complement C5 Induced by
Peng L; Gao J; Hu Z; Zhang H; Tang L; Wang F; Cui L; Liu S; Zhao Y; Xu H; Su X; Feng X; Fang Y; Chen J
Front Cell Infect Microbiol; 2021; 11():732163. PubMed ID: 35087765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
